VP of Scientific Affairs Marion Lanteri recently joined the International Plasma and Fractionation Association (IPFA) executive board, as CTS joined as a member. She said of her appointment, “It is my honor to represent CTS internationally and to create new opportunities. I am also grateful that CTS invested in this membership, and I will make the best of it.”
IPFA’s mission is to support and promote the activities of nonprofit organizations around the globe engaged in the collection and fractionation of plasma to enable robust, safe supply and patient access to plasma-derived medicines. Additionally, through education and collaboration with stakeholders, they advocate for public health values and donor health protection.
According to an IPFA article, CTS’s membership brings a new category of contribution to IPFA from nonprofit research and clinical testing institutions. They describe this sector as being at the heart of the association and bringing together the different stakeholders that CTS represents and works with.
President & CEO Sally Caglioti said of the news, “I’m grateful to Marion for representing us with IPFA. Professional networking is a big part of why we have had so many growth opportunities at CTS. Building relationships and trust with external colleagues opens up all kinds of doors.”
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
We have now added a new section called the "Assay History List" to the "At A Gla...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...